| 1) Core items |
| Test code |
Test name |
Clinical description |
| X402 |
Anti-mullerian hormone (AMH) |
Evaluation of ovarian reserve |
| E427 |
Estradiol (E2) |
Assessment of follicular phase and ovulatory function |
| E421 |
Follicle Stimulating Hormone (FSH) |
Assessment of decreased ovarian function and menopause |
| E422 |
Luteinizing Hormone (LH) |
Evaluation of ovulation status and pituitary function |
| E423 |
Prolactin |
Differential diagnosis of galactorrhea and amenorrhea |
| L959 |
Testosterone |
Assessment of androgen excess conditions, including polycystic ovary syndrome (PCOS) |
| E403 |
Thyroid Stimulating Hormone (TSH) |
Measurement of thyroid-stimulating hormone (TSH) concentration |
| E406 |
Thyroxine (T4), Free |
Measurement of free thyroxine (Free T4) concentration |
| 2) Optional items |
| Test code |
Test name |
Clinical description |
| W367 |
17α-OH progesterone [CIA] |
Differential diagnosis of congenital adrenal hyperplasia |
| C404 |
25-Hydroxyvitamin D (25 OH Vitamin D) |
Assessment of vitamin D deficiency and calcium absorption |
| C547 |
Bone alkaline phosphatase [S] |
Bone formation marker; assessment of bone formation activity |
| S641 |
C-terminal telopeptides (CTX) |
Bone resorption marker; evaluation of bone loss severity |
| P081 |
DHEA-S [ECLIA] |
Differential diagnosis of adrenal-related amenorrhea |
| P767 |
Free testosterone [CIA] |
Assessment of androgen excess conditions, including PCOS |
| D126 |
Human papillomavirus genotyping [Multiplex real-time PCR] |
Identification of high-risk human papillomavirus (HPV) types |
| E412 |
Intact parathyroid hormone (PTH) |
Evaluation of parathyroid function (assessment of secondary osteoporosis) |
| K662 |
Osteocalcin |
Reflects osteoblast activity; supportive indicator for predicting treatment response |
| L455 |
ROMA Score |
Marker for early detection and risk assessment of ovarian cancer |
| 3) Supplementary items |
| Test code |
Test name |
Clinical description |
| E539 |
Estriol, Unconjugated [S] |
Assessment of estrogen activity |
| E428 |
Progesterone |
Evaluation of luteal phase function and ovulation status |
